Complement activation, endothelin-1 and neuropeptide Y in relation to the cardiovascular response to endotoxin-induced systemic inflammation in healthy volunteers

What Was Tested

Researchers studied Endothelin-1 and Neuropeptide Y in this clinical trial publication.

Endotoxin is a major stimulus for triggering the host response in septicaemia.

The pathophysiology of sepsis involves activation of the vascular endothelium and leukocytes, resulting in the release of various mediators, e.g. cytokines, nitric oxide (NO), endothelin (ET-1) and complement factors.

Who Took Part

By PubMed's age tags, the people studied were adults, men only.

Eleven healthy men had venous, arterial and pulmonary arterial catheters placed for continuous haemodynamic measuring.

How the Study Was Run

In design terms this was a parallel-group study.

Groups ran in parallel: each of the participants stayed in one arm throughout.

After 30 min rest endotoxin (E.

Coli 4 ng kg(-1), Lot G1) was intravenously administered.

Blood samples from pulmonary and arterial catheters were collected hourly over 4 h.

What Was Measured

The researchers evaluated the blood levels of complement activation, ET-1 and neuropeptide Y (NPY) in parallel with the haemodynamic and oxygen transport response during human experimental endotoxemia.

PubMed files the paper under topics including Body Temperature, Complement Activation, Endothelin-1, Endotoxemia, Endotoxins, Hemodynamics and Inflammation.

What This Means in Plain Language

The paper is a parallel-group study of Endothelin-1 and Neuropeptide Y.

The abstract goes on to report its results in about 6 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2004 (Acta anaesthesiologica Scandinavica), a journal based in England.

More context: the Endothelin-1 compound page and the Neuropeptide Y compound page, all human trials.